Red blood cell endothelial nitric oxide synthase: A major player in regulating cardiovascular health
British Journal of Pharmacology · 2026
DOI: 10.1111/bph.16230 ↗At a glance
Übersichtsarbeit in British Journal of Pharmacology, 2026. Written by Anthea LoBue and 7 co-authors. Institution: Myocardial Infarction Research Laboratory, Department of Cardiology, Pulmonology, and Angiology, Medical Faculty, Heinrich-Heine-University, Düsseldo…. Major MEDLINE topics: Erythrocytes, Nitric Oxide Synthase Type III, Cardiovascular Diseases, Cardiovascular System. Cited 25 times so far (Crossref); 132 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: German Research Council, Forschungskommission, Medical Faculty, Heinrich-Heine University Düsseldorf.
Abstract (original language)
Red blood cells (RBCs) have traditionally been seen as simple carriers of gases and nutrients in the body. One important non‐canonical function of RBCs in the cardiovascular system is the regulation of nitric oxide (NO) metabolism. It has been shown that RBCs can scavenge NO, transport NO metabolites and produce NO in hypoxic conditions, thereby inducing hypoxic vasodilation. RBCs also express endothelial nitric oxide synthase (eNOS). However, the physiological significance of RBC eNOS has been controversial for many years. This review article provides a comprehensive overview of the experimental research on RBC eNOS signalling in vivo. The data show that RBC eNOS signalling modulates intracellular NO production and NO–haem levels, as well as participating in extracellular paracrine NO metabolite signalling, which contributes to regulating peripheral vascular resistance, blood pressure and cardioprotection. Additionally, this article explores the molecular mechanisms of sytemic regulation mediated by RBC eNOS and the implications of RBC eNOS in cardiovascular health and disease. LINKED ARTICLES This article is part of a themed issue Recent Innovations in Targeting Redox Biology for Therapeutics. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v183.1/issuetoc
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Myocardial Infarction Research Laboratory, Department of Cardiology, Pulmonology, and Angiology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
- Department of Nephrology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
- Department of Cardiology Pulmonology and Angiology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
- CARID, Cardiovascular Research Institute Düsseldorf, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
ORCID profiles: Johannes Stegbauer
Funding
- German Research Council
- Forschungskommission, Medical Faculty, Heinrich-Heine University Düsseldorf
Cite
APA
LoBue, A., Heuser, S. K., Lindemann, M., Li, J., Rahman, M., Kelm, M., Stegbauer, J., & Cortese-Krott, M. M. (2026). Red blood cell endothelial nitric oxide synthase: A major player in regulating cardiovascular health. British Journal of Pharmacology. https://doi.org/10.1111/bph.16230
Vancouver
LoBue A, Heuser SK, Lindemann M, Li J, Rahman M, Kelm M, et al. Red blood cell endothelial nitric oxide synthase: A major player in regulating cardiovascular health. British Journal of Pharmacology. 2026. doi:10.1111/bph.16230
BibTeX
@article{LoBue2026,
author = {LoBue, Anthea and Heuser, Sophia K and Lindemann, Marla and Li, Junjie and Rahman, Masudur and Kelm, Malte and Stegbauer, Johannes and Cortese-Krott, Miriam M},
title = {Red blood cell endothelial nitric oxide synthase: A major player in regulating cardiovascular health},
journal = {British Journal of Pharmacology},
year = {2026},
doi = {10.1111/bph.16230}
}
EUVIMED